📊 RTEZ Key Takeaways
Is REST EZ Inc. (RTEZ) a Good Investment?
REST EZ Inc. exhibits complete operational collapse with zero revenue, zero operating cash flow, and zero profitability across all metrics. The company functions as a cash shell with minimal assets and no evidence of active pharmaceutical operations or business recovery prospects.
Why Buy REST EZ Inc. Stock? RTEZ Key Strengths
- Zero financial leverage (0.0x debt/equity)
- Modest cash reserves ($300k) provides temporary runway
- Recent financial data available for analysis
RTEZ Stock Risks: REST EZ Inc. Investment Risks
- Total revenue loss (-100% YoY) with zero current sales
- Zero operating cash flow indicates inability to sustain operations
- Minimal total assets ($300k) insufficient to fund pharmaceutical development
- No insider trading activity in 90 days signals loss of management confidence
- Rapid cash depletion inevitable without business operations
- Pharmaceutical sector requires substantial capital with no evidence of investment
Key Metrics to Watch
- Revenue reinstatement or operational restart
- Operating cash flow generation timeline
- Cash burn rate and months of runway remaining
REST EZ Inc. (RTEZ) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
RTEZ Profit Margin, ROE & Profitability Analysis
RTEZ vs Healthcare Sector: How REST EZ Inc. Compares
How REST EZ Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is REST EZ Inc. Stock Overvalued? RTEZ Valuation Analysis 2026
Based on fundamental analysis, REST EZ Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
REST EZ Inc. Balance Sheet: RTEZ Debt, Cash & Liquidity
RTEZ Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: REST EZ Inc.'s revenue has declined by 99% over the 5-year period, indicating business contraction. The most recent EPS of $0.00 indicates the company is currently unprofitable.
RTEZ Revenue Growth, EPS Growth & YoY Performance
RTEZ Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | N/A | N/A | $0.00 |
| Q2 2026 | N/A | N/A | $0.00 |
| Q1 2026 | N/A | N/A | $0.00 |
| Q3 2025 | N/A | -$1.2K | $0.00 |
| Q2 2025 | N/A | -$33 | $0.00 |
| Q1 2025 | N/A | -$33 | $0.00 |
| Q3 2024 | N/A | -$1.2K | $0.00 |
| Q2 2024 | N/A | -$7.7K | $-0.38 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
RTEZ SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for REST EZ Inc. (CIK: 0001733861)
📋 Recent SEC Filings
❓ Frequently Asked Questions about RTEZ
What is the AI rating for RTEZ?
REST EZ Inc. (RTEZ) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are RTEZ's key strengths?
Claude: Zero financial leverage (0.0x debt/equity). Modest cash reserves ($300k) provides temporary runway.
What are the risks of investing in RTEZ?
Claude: Total revenue loss (-100% YoY) with zero current sales. Zero operating cash flow indicates inability to sustain operations.
What is RTEZ's revenue and growth?
REST EZ Inc. reported revenue of $0.0.
Does RTEZ pay dividends?
REST EZ Inc. does not currently pay dividends.
Where can I find RTEZ SEC filings?
Official SEC filings for REST EZ Inc. (CIK: 0001733861) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is RTEZ's EPS?
REST EZ Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is RTEZ a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, REST EZ Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is RTEZ stock overvalued or undervalued?
Valuation metrics for RTEZ: ROE of 0.0% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy RTEZ stock in 2026?
Our dual AI analysis gives REST EZ Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is RTEZ's free cash flow?
REST EZ Inc.'s operating cash flow is $0.0, with capital expenditures of N/A.
How does RTEZ compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE 0.0% (avg: 15%), current ratio N/A (avg: 2).